Authors
Loading...
Observational analysis shows choroidal thickness correlates with decreased choroidal blood flow in neovascular AMD, suggesting Brolucizumab's role in managing this disease.
Aki Booka (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: